MERCURY LABORATORIES
Back to Balance Sheet
|
MERCURY LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹1.26 Cr | ₹1.89 Cr | ₹2.23 Cr | ₹2.13 Cr | ₹1.74 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of MERCURY LABORATORIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹1.26 Cr |
Mar2023 | ₹1.89 Cr |
Mar2022 | ₹2.23 Cr |
Mar2021 | ₹2.13 Cr |
Mar2020 | ₹1.74 Cr |
How is Deferred Tax Assets / Liabilities of MERCURY LABORATORIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1.26 Cr | -33.51 | |
Mar2023 | ₹1.89 Cr | -15.16 | |
Mar2022 | ₹2.23 Cr | 4.79 | |
Mar2021 | ₹2.13 Cr | 22.30 | |
Mar2020 | ₹1.74 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of MERCURY LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MERCURY LABORATORIES | ₹110.3 Cr | -0.1% | -0.5% | 21.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹446,684.0 Cr | 2.9% | 6.4% | 48.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,935.0 Cr | 0.5% | -2.1% | 59.2% | Stock Analytics | |
CIPLA | ₹121,639.0 Cr | 2.3% | 1% | 20.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹115,931.0 Cr | 3.5% | 15.7% | 20.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,876.4 Cr | -0.1% | 2.3% | 41.1% | Stock Analytics |
MERCURY LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MERCURY LABORATORIES | -0.1% |
-0.5% |
21.1% |
SENSEX | -0.7% |
-1.6% |
11.1% |
You may also like the below Video Courses